Transfer of Oma Savings Bank Plc's own shares for incentive scheme reward payment
OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE, 25 MAY 2025 AT 11.30 AM EET, CHANGES IN COMPANY'S OWN SHARES
Transfer of Oma Savings Bank Plc's own shares for incentive scheme reward payment
Advertisement
The Board of Directors of Oma Savings Bank Plc (OmaSp or Company) has resolved to transfer 4 819 own shares held by the company without consideration to participants of the share-based incentive scheme 2022-2023 for payment of the reward instalment 2025 in accordance with the plan terms and conditions. The shares will be transferred as a reward from the plan on 21 May 2025.
The transfer of own shares is based on the authorisation granted by the Annual General Meeting held on 8 April 2025.
After the transfer of shares, Oma Savings Bank Plc holds 132 200 own shares in treasury.
Oma Savings Bank Plc
Additional information:
Karri Alameri, CEO, tel. +358 45 656 5250, [email protected]
DISTRIBUTION:
Nasdaq Helsinki Ltd
Major media
www.omasp.fi
OmaSp is a solvent and profitable Finnish bank. About 500 professionals provide nationwide services through OmaSp's 48 branch offices and digital service channels to over 200,000 private and corporate customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners' products. The intermediated products include credit, investment and loan insurance products. OmaSp is also engaged in mortgage banking operations.
OmaSp core idea is to provide personal service and to be local and close to its customers, both in digital and traditional channels. OmaSp strives to offer premium level customer experience through personal service and easy accessibility. In addition, the development of the operations and services is customer-oriented. The personnel is committed and OmaSp seeks to support their career development with versatile tasks and continuous development. A substantial part of the personnel also own shares in OmaSp.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Madison Pacific Properties Inc. (TSX: MPC and MPC.C) announces results of Annual General Meeting
VANCOUVER, British Columbia, June 19, 2025 (GLOBE NEWSWIRE) -- Madison Pacific Properties Inc. (the Company), reports the voting results of the Annual General Meeting of its shareholders held June 19, 2025 in Vancouver, British Columbia. The following five nominees were re-elected as directors of the Company by the following votes: Nominee Votes For Percent Votes Against Percent Sam Grippo 4,644,381 99.99 % 400 0.01 % Michael W. Delesalle 4,644,381 99.99 % 400 0.01 % Mark E. Elliott 4,644,381 99.99 % 400 0.01 % Jonathan H. B. Rees 4,644,381 99.99 % 400 0.01 % John DeLucchi 4,644,304 99.99 % 477 0.01 % In addition, PricewaterhouseCoopers LLP was re-appointed as the auditor for the Company. About the Company: Madison Pacific Properties Inc. is a Vancouver-based real estate company. Contact: Mr. John DeLucchi Ms. Bernice Yip President & CEO Chief Financial Officer Telephone: (604) 732-6540 (604) 732-6540 Address: 389 West 6th Avenue Vancouver, B.C. V5Y 1L1Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Yahoo
Shareholders Approve Bylaw Amendments at Regeneron Pharmaceuticals (NasdaqGS:REGN) Annual Meeting
Regeneron Pharmaceuticals recently conducted its Annual General Meeting, resulting in approved changes to its company bylaws. The amendments, along with the promising results from the EVEREST Phase 4 study, indicate strong governance and product development. Despite these developments, the company's share price remained relatively flat over the past week, aligning with the broader market's stability. While the market showed a 9.9% rise over the past year and anticipates a 15% annual earnings growth, the past week's events might have lent weight to this upward trend, yet they did not result in a notable price shift for Regeneron. Buy, Hold or Sell Regeneron Pharmaceuticals? View our complete analysis and fair value estimate and you decide. Uncover the next big thing with financially sound penny stocks that balance risk and reward. Regeneron Pharmaceuticals' recent governance enhancements and promising drug trial results highlighted at the Annual General Meeting suggest solid groundwork for potential growth. However, the short-term stability in share price implies these developments have not yet fully influenced market sentiment. Over a longer-term period, specifically three years, the company's total return, including share price and dividends, has declined by 12.24%, suggesting challenges in maintaining momentum in a highly competitive biotech landscape. While the broader market showed a 9.9% rise over the past year, Regeneron underperformed, emphasizing the need for effective execution of its strategic initiatives. The anticipation surrounding the EVEREST study and other pipeline advancements could positively affect revenue and earnings forecasts, potentially aligning future market expectations with current analyst projections for a price target of US$727.21, given the current price of US$558.52. This presents an opportunity for price appreciation should Regeneron successfully capitalize on its expansive product pipeline and strategic investments. Review our historical performance report to gain insights into Regeneron Pharmaceuticals' track record. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:REGN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Yahoo
RINA acquires Foreship, bolstering marine consulting services
RINA, an engineering consultancy, has announced the acquisition of Foreship, a Finnish naval architecture and marine engineering firm. This strategic move is set to enhance RINA's marine engineering consulting services and reinforce its presence in Northern Europe. Headquartered in Helsinki, Foreship reported revenues of €15.2m (approximately $16m) in 2024 and boasts a workforce of more than 90 professionals across eight international offices, including the US, UK, and Estonia. The company is acclaimed for its expertise in cruise ship design, vessel energy efficiency, and sustainable marine technologies. RINA general manager and CEO Carlo Luzzatto said: 'We are proud to welcome into our group a company that shares our core values of independence, innovation, and engineering excellence. This acquisition aligns with our strategic plan to become an increasingly essential reference point for our clients, supporting them with our broad-based knowledge. 'Foreship's solid reputation and global customer base, including major cruise lines and shipping companies, make it a natural fit for our fast-growing marine consulting business. Foreship reputation as a trusted independent advisor is seen as a core asset that RINA aims to preserve and enhance.' The integration of Foreship's unique naval architecture capabilities is expected to create significant synergies within RINA Consulting. It will also provide opportunities to expand RINA's market share in maritime consultancy, particularly in areas such as complex retrofits, new fuel integrations, and digital transformation. Foreship will operate within the framework of RINA Consulting, adhering to RINA's governance and organisational model. Foreship CEO Lauri Haavisto said: 'Foreship's vision is to lead in sustainable passenger ship conversions, new builds, and consultancy. Joining forces with a global partner like RINA will accelerate our growth, expand our knowledge, and strengthen our client relationships, while continuing to foster the close collaboration we value.' RINA's acquisition was facilitated by Lazard, which served as the financial advisor. Bain & Company provided support in commercial due diligence, while PwC assisted with financial and tax due diligence. Legal counsel for the transaction was provided by Borenius Attorneys. In April, RINA, along with Eni and Fincantieri, introduced a new study titled 'Sustainable Maritime Transport Outlook,' which aims to guide the decarbonisation of the maritime transport sector. Prepared with technical support from Bain & Company Italy, the study offers a comprehensive analysis of the pathways, impacts, and investments necessary to achieve carbon neutrality in the maritime industry by 2050. "RINA acquires Foreship, bolstering marine consulting services" was originally created and published by Ship Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
